Jazz Pharmaceuticals (JAZZ) Total Debt Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 6.94% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 50.25% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.07% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Jazz Pharmaceuticals | 14.35 Bn | 12.51 Bn | 934.80 Mn | -2.18% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.18% |
| Dec 31, 2025 | -2.18% |
| Sep 30, 2025 | -2.18% |
| Jun 30, 2025 | -3.78% |
| Mar 31, 2025 | -3.77% |
| Dec 31, 2024 | 0.32% |
| Sep 30, 2024 | -0.89% |
| Jun 30, 2024 | -5.39% |
| Mar 31, 2024 | 39.54% |
| Dec 31, 2023 | 39.71% |
| Sep 30, 2023 | 39.89% |
| Jun 30, 2023 | 39.57% |
| Mar 31, 2023 | 52.58% |
| Dec 31, 2022 | 52.71% |
| Sep 30, 2022 | 52.83% |
| Jun 30, 2022 | 55.50% |
| Mar 31, 2022 | 55.61% |
| Dec 31, 2021 | 55.91% |
| Sep 30, 2021 | 57.93% |
| Jun 30, 2021 | 61.77% |
| Mar 31, 2021 | 9.93% |
| Dec 31, 2020 | 9.83% |
| Sep 30, 2020 | 9.73% |
| Jun 30, 2020 | 7.95% |
| Mar 31, 2020 | -4.96% |
| Dec 31, 2019 | -7.48% |
| Sep 30, 2019 | -9.77% |
| Jun 30, 2019 | 10.74% |
| Mar 31, 2019 | 10.53% |
| Dec 31, 2018 | 10.34% |
| Sep 30, 2018 | 7.32% |
| Jun 30, 2018 | 5.22% |
| Mar 31, 2018 | 5.59% |
| Dec 31, 2017 | 5.60% |
| Sep 30, 2017 | 5.62% |
| Jun 30, 2017 | 11.80% |
| Mar 31, 2017 | 16.10% |
| Dec 31, 2016 | 54.53% |
| Sep 30, 2016 | 58.23% |
| Jun 30, 2016 | 28.77% |
| Mar 31, 2016 | 37.94% |
| Dec 31, 2015 | 37.54% |
| Sep 30, 2015 | 40.77% |
| Jun 30, 2015 | 42.93% |
| Jun 30, 2014 | 568.77% |
| Dec 31, 2013 | 125.37% |